Antidiabetic and Antihyperlipidemic Activities of the Leaf Latex Extract of Aloe megalacantha Baker (Aloaceae) in Streptozotocin-Induced Diabetic Model

Table 2

The effects of the leaf latex of Aloe megalacantha on postprandial glycemia in nondiabetic mice.

Group	Blood glucose level(mg/dl)
	0 min	30 min	60 min	120 min	180 min
DW10	103.67 ± 3.49	183.33 ± 9.16	155.17 ± 6.91	109.00 ± 3.76	101.83 ± 3.60
GL5	96.67 ± 1.89	123.56 ± 10.8	77.50 ± 1.68	67.67 ± 2.43	61.67 ± 2.44
AM100	99.33 ± 3.79	135.67 ± 15.98	74.17 ± 7.55	61.76 ± 8.45	69.78 ± 7.69
AM200	101.17 ± 2.99	161.83 ± 13.93	62.17 ± 9.29	55.95 ± 7.35	62.00 ± 4.29
AM400	100.00 ± 2.74	171.17 ± 11.08	83.83 ± 6.99	75.61 ± 10.40	71.00 ± 4.21

Results are expressed in mean ± S.E.M, n = 6, DW10 = distilled water 10 ml/kg, GL5 = glibenclamide 5mg/kg, AM100 = A. megalacantha extract 100 mg/kg, AM200 = A. megalacantha extract 200mg/kg, AM400 = A. megalacantha extract 400mg/kg, compared with negative control group, b compared with BGL at 0 min, c compared with BGL after 30 min, compared with glibenclamide 5mg/kg 1p < 0.05, 2p < 0.01,3p < 0.001